SCHEMBL14768441

SCHEMBL14768441

CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CCc1ccoc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
CYP3A4 P08684 4/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 2/20 0.42
UGT1A1 P22309 1/20 0.42
ALOX5 P09917 1/20 0.42
SQLE Q14534 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP3A5 P20815 1/20 0.40
CYP2C19 P33261 1/20 0.40
BACE1 P56817 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14768442 0.75 KMT2A (0.47) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL14767595 0.75 KMT2A (0.47) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL14768450 0.73 KMT2A (0.46) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL11860936 0.73 KMT2A (0.48) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL11860941 0.73 KMT2A (0.48) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL14767601 0.73 KMT2A (0.48) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL14767632 0.73 KMT2A (0.48) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL11856615 0.72 KMT2A (0.52) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL11856631 0.72 KMT2A (0.52) KMT2ACYP3A4MAPTMEN1ALDH1A1
SCHEMBL14767623 0.70 KMT2A (0.48) KMT2ACYP3A4MAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR1H3, HIF1AN KMT2A 1404/4885CYP3A4 1962/4885MAPT 4854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.